Efficacy of High-dose Chemotherapy and Autologous Stem Cell transplant for Recurrent Wilms' Tumor: A Meta-analysis

Long-term survival of relapsed Wilms' tumor patients is about 40% to 70%. Modern second-line treatment consists of either (a) salvage chemotherapy±radiation therapy (CT) or (b) chemotherapy followed by high-dose chemotherapy and autologous hematopoietic stem cell rescue (ASCR). Here, we conduct an i